Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT05638412 · ClinicalTrials.gov registry record · NA

Investigating the Impact of JASPER Behavioral Therapy in Children With Down Syndrome

A NA study of Down Syndrome, sponsored by Boston Children's Hospital.

Active
Registry status
NA
Development phase
57
Enrollment target
1
Study location

NCT05638412 is a NA study of Down Syndrome that is active but no longer recruiting, run by Boston Children's Hospital. The registered enrollment target is 57 participants, below the 2,471-participant average among 54 other Down Syndrome trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT05638412, a NA study of Down Syndrome, is active but no longer recruiting, sponsored by Boston Children's Hospital.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
57 participants
Enrollment target
1
Study location

Study Summary

In this study, investigators will study the impact of a 1:1 caregiver coaching intervention using the JASPER (Joint Attention, Symbolic Play, Engagement, Regulation) behavioral therapy curriculum compared to a psychoeducational curriculum that will be provided to caregivers for self-directed learning. Investigators want to determine the impact of both interventions on the child's development and behavior, and caregiver implementation of strategies.

Conditions Studied

Interventions

  • BEHAVIORAL JASPER
  • BEHAVIORAL Psychoeducational Curriculum

Study Locations (1)

Massachusetts

  • Boston Children's Hospital - Boston

Trial Details

FieldValue
Enrollment Target 57 participants
Start Date 2023-01-23
Est. Completion 2025-08
Phase NA

Sponsor

Boston Children's Hospital

462 total trials

What the Registry Record Tells You About NCT05638412

The ClinicalTrials.gov registry entry for NCT05638412 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 57 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 2,471-participant average among 54 other Down Syndrome trials with a reported enrollment target (98% lower). The listed sponsor is Boston Children's Hospital, which has 462 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Down Syndrome appearing as the primary indexed condition, and to 2 interventions - of which JASPER is the first listed.

NCT05638412 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.

Frequently Asked Questions

What is clinical trial NCT05638412 about?

NCT05638412 is a clinical study titled "Investigating the Impact of JASPER Behavioral Therapy in Children With Down Syndrome". In this study, investigators will study the impact of a 1:1 caregiver coaching intervention using the JASPER (Joint Attention, Symbolic Play, Engagement, Regulation) behavioral therapy curriculum compared to a psychoeducational curriculum that will be provided to caregivers for self-directed learnin...

What is the current status of trial NCT05638412?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 57 participants. The study started on 2023-01-23. Estimated completion is 2025-08.

What conditions does trial NCT05638412 study?

This clinical trial studies the following conditions: Down Syndrome.

What interventions are being tested in trial NCT05638412?

The interventions under investigation include: JASPER (BEHAVIORAL), Psychoeducational Curriculum (BEHAVIORAL).

Who is sponsoring clinical trial NCT05638412?

This trial is sponsored by Boston Children's Hospital, which has 462 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT05638412 being conducted?

This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Down Syndrome

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.